Effects of Fluid Infusion on Postoperative Vomiting in Pediatric Patients Undergoing Otorhinolaryngological Surgery
FLUIDVOMIT
Effects of Intraoperative Fluid Infusion on Postoperative Vomiting in Pediatric Patients Undergoing Otorhinolaryngological Surgery
1 other identifier
interventional
160
1 country
1
Brief Summary
Otorhinolaryngological surgery is one of the commonly applied procedures surgical treatments of children in the world. Postoperative vomiting (POV) is an important part of the management of pediatric anesthesia in this surgery that is also related with these surgical procedures. Postoperative vomiting is one of the most common complication of this surgery and may cause patients to receiving anesthesia again and stay longer in the hospital.The use of effective fluid therapy might be a safe way to reduce POV. There are many studies of fluid therapy adult patients on the other hands the number of children studies are limited. The aim of this study was to evaluate the POV effect of intraoperative hydration with 0.9 NaCl solution in children undergoing otorhinolaryngological surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedFirst Submitted
Initial submission to the registry
March 26, 2018
CompletedFirst Posted
Study publicly available on registry
April 2, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2018
CompletedDecember 5, 2018
December 1, 2018
5 months
March 26, 2018
December 4, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
vomiting
Both nausea and vomiting were assessed on a four point scale: 0=no nausea/vomit, 1=mild nausea/vomit, patient not requesting metoclopramide, 2=nausea/vomit, patient requesting metoclopramide and 3=nausea/vomit resistant to treatment
postoperative first 30 min
Secondary Outcomes (1)
Pain
postoperative first 30 min
Study Arms (2)
Group I (%0.9 NaCl 10ml/kg)
ACTIVE COMPARATORThe group (Group 1) received 10 ml kg-1 throughout the entire surgical procedure. Four point scale using scored vomiting. m CHEOPS Scale using scored between 0-10.
Group II (%0.9 NaCl 20ml/kg)
ACTIVE COMPARATORThe group (Group 2) received 30 ml kg-1 throughout the entire surgical procedure. Four point scale using scored vomiting. m CHEOPS Scale using scored between 0-10.
Interventions
Eligibility Criteria
You may qualify if:
- years
- ASA I-II
You may not qualify if:
- Gastroesafageal reflu
- Premedication antiemetic
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Adnan Menderes University Training and Research Hospital
Aydin, 09100, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
sinan yılmaz
Aydin Adnan Menderes University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- The postoperative assessment following the anesthesiologist, nurse and parents were blind during the entire study group
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Adnan Menderes University
Study Record Dates
First Submitted
March 26, 2018
First Posted
April 2, 2018
Study Start
January 1, 2018
Primary Completion
June 1, 2018
Study Completion
June 1, 2018
Last Updated
December 5, 2018
Record last verified: 2018-12